Genetic Technologies (ASX:GTGDA) - Stock Price, News & Analysis

GTGDA Stock Overview

A molecular diagnostics company, provides predictive genetic testing and risk assessment tools to help physicians manage people’s health in the America, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.

About the company

GTGDA fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	0/6
Past Performance	0/6
Financial Health	4/6
Dividends	0/6

Rewards

Risk Analysis

Shares are highly illiquid

Has less than 1 year of cash runway

Currently unprofitable and not forecast to become profitable over the next 3 years

Shareholders have been diluted in the past year

+ 1 more risk

Genetic Technologies Limited Competitors

Memphasys

ASX:MEM

AU$11.1m

OncoSil Medical

ASX:OSL

AU$16.7m

EZZ Life Science Holdings

ASX:EZZ

AU$81.5m

Cryosite

ASX:CTE

AU$61.0m

Price History & Performance

Summary of all time highs, changes and price drops for Genetic Technologies
Historical stock prices
Current Share Price	AU$0.17
52 Week High	AU$0.20
52 Week Low	AU$0.13
Beta	0.68
11 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	12.90%

Recent updates

Shareholder Returns

	GTGDA	AU Life Sciences	AU Market
7D	16.7%	4.7%	-0.3%
1Y	n/a	-6.9%	8.3%

Return vs Industry: Insufficient data to determine how GTGDA performed against the Australian Life Sciences industry.

Return vs Market: Insufficient data to determine how GTGDA performed against the Australian Market.

Price Volatility

Is GTGDA's price volatile compared to industry and market?
GTGDA volatility
GTGDA Average Weekly Movement	n/a
Life Sciences Industry Average Movement	8.3%
Market Average Movement	8.2%
10% most volatile stocks in AU Market	16.3%
10% least volatile stocks in AU Market	3.2%

Stable Share Price: GTGDA has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine GTGDA's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1987	60	Simon Morriss	genetype.com

Genetic Technologies Limited, a molecular diagnostics company, provides predictive genetic testing and risk assessment tools to help physicians manage people’s health in the United States, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. It operates in two segments, EasyDNA and GeneType/Corporate. The company offers BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer.

Genetic Technologies Limited Fundamentals Summary

How do Genetic Technologies's earnings and revenue compare to its market cap?
GTGDA fundamental statistics
Market cap	AU$17.31m
Earnings (TTM)	-AU$11.75m
Revenue (TTM)	AU$10.35m

1.7x

P/S Ratio

-1.5x

P/E Ratio

Is GTGDA overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
GTGDA income statement (TTM)
Revenue	AU$10.35m
Cost of Revenue	AU$4.34m
Gross Profit	AU$6.01m
Other Expenses	AU$17.76m
Earnings	-AU$11.75m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)	-0.10
Gross Margin	58.10%
Net Profit Margin	-113.56%
Debt/Equity Ratio	0%

How did GTGDA perform over the long term?

See historical performance and comparison

Genetic Technologies ASX:GTGDA Stock Report